Despite significant development of successful genetic and pharmacological preclinical treatment strategies in mice there is still no cure for LAMA2-CMD, the second-most common form of congenital muscular dystrophy [1,38,39]. The gene discussed is LAMA2; the disease is congenital muscular dystrophy.